Learn about the roles that one’s sex (determined by genes and chromosomes), and gender (social role and preferred orientation) play in the risk for developing Alzheimer’s in women. We examine how they may impact the course of the disease.
AD, if we look at the evidence, is a much larger burden for women than for men. Nearly two-thirds of people diagnosed with AD are women. A similar proportion of caregivers is women. As a woman, Elise’s sex (determined by her inherited sex chromosomes) and her gender (her social role and preferred orientation) play important roles in her risk for developing AD and for the course her disease will take. Clinicians and researchers have been learning more about this issue lately, and here are some of the things they’ve found:
- Elise’s risk of developing AD is greater than a man’s. A 65-year-old woman, for example, has a 12 percent risk of developing AD during the remainder of her life while the risk for a 65-year-old man is only about half as great (6.3 percent). This difference may partly reflect women’s longer survival. Sex also influences Elise’s risk through her female hormones. Estrogen protects the healthy brain and exerts a protective anti-AD effect up to menopause. There is strong evidence, for example, that a woman whose ovaries are removed before natural menopause is at significantly higher risk for developing AD unless she promptly receives estrogen as a hormone replacement therapy. After a medically or surgically induced menopause, the estrogen must be given soon because estrogen seems to have a different effect on older, less healthy brain cells. Based on the results of the influential Women’s Health Initiative Memory (WHIM) study, researchers have suggested that estrogen can be harmful if started more than five years after the last menstrual period. The reasons for this are still being investigated.
- Sex also affects the rate and impact of risk factors. The E4 version of the apolipoprotein gene, referred to as ApoE4, for example, is a more potent risk factor for men than for women. However, women with adult-onset diabetes are at greater risk for developing dementia than are men with the same illness.
- Elise’s gender, her culturally determined role behavior, will also affect her risk of developing AD. As a woman in her 80s, she was raised during an era when men typically reached a higher level of education. Educational attainment is an important AD preventive factor. The educational gap between men and women has changed in recent years, and the most current census shows women generally achieving a higher educational status than men. Women of Elise’s era also tended to be less physically active than men, and physical activity is another important anti-AD protective factor. On the other hand, Elise’s generation of women smoked and drank alcohol less heavily than men, so she would have been less affected by these risk factors. Unfortunately, women of more recent generations have increased their use of tobacco and alcohol.
- Elise is widowed, which would be a more serious AD risk factor for a man than for a woman. Although her son has offered to be a caregiver, the greater burden is likely to fall on Alan’s wife. The majority of AD caregivers are wives and daughters, and women caregivers experience a greater level of stress in this caretaking role. Elise’s illness, too, is likely to go on for a longer time than would a man’s. Women are diagnosed earlier, and although their decline progresses faster they nonetheless survive longer than men with AD.
- In contrast to caring for a man with AD, a job that can be complicated because of restlessness and aggression, the difficulty in caring for Elise may result from her prolonged decline and survival. Personal care needs will increase over time, and she may eventually be unable to communicate effectively, eat without assistance, or walk safely. She is less likely than a man to become aggressive, but more likely to experience and complain of hallucinations and paranoid delusions. One study found that women with dementia hospitalized because of behavioral problems were more likely to respond and be able to return home than were the men.
- Alzheimer’s Disease Toolkit (Helpful Information to Understand and Manage Alzheimer's Disease)
- Expert Information on Alzheimer's Disease (Articles)
- Alzheimer’s Disease in Men (Article)
- Decreasing Your Risk of Alzheimer’s (Article)
- What Is Your Risk?—Heredity and Late-Onset Alzheimer's Disease (Article)
- Is Alzheimer’s a Genetic Disease (Article)
- Beyond Brain Games: What’s a Brain-Healthy Lifestyle? (Article)
- The Challenging Behaviors of Alzheimer’s Disease - Part One (Article)
- Is it Alzheimer's? (Article)
- Understanding Alzheimer's Disease: It's Not Just Forgetfulness (Publication)
Rocca WA, Mielke MM, Vemuri P, et all. Sex and gender differences in the causes of dementia: a narrative review. Maturitas 2014;79:196-201.
Mielke MM, Vemuri P, Rocca WA. Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences. Clinical Epidemiology 2014;6:37-46.
Podcasy JL, Epperson Neill. Considering sex and gender in Alzheimer disease and other dementias. Dialogues in Clinical Neuroscience 2016;18:437-446.
Nebel RA, Aggarwal NT, Barnes LL, et al. Understanding the impact of sex and gender in Alzheimer's disease: A call to action. Alzheimer's & Dementia 2018;1-13.
Kiamura T, Kitamura M, Shoryoku H, et al. Gender differences in clinical manifestations and oucomes among hospitalized patients with behavioral and psychological symptoms of dementia. J Clin Psychiatry 2012;73:1548-1554.
Canevelli M, Quarata F, Remiddi F, et al. Sex and gender differences in the treatment of Alzheimer's disease: A systematic review of randomized controlled trials. Pharmacological Research 2017;115:218- 223.
This content was last updated on: November 5, 2018
The information provided here is a public service of the BrightFocus Foundation and should not in any way substitute for personalized advice of a qualified healthcare professional; it is not intended to constitute medical advice. Please consult your physician for personalized medical advice. BrightFocus Foundation does not endorse any medical product, therapy, or resources mentioned or listed in this article. All medications and supplements should only be taken under medical supervision. Also, although we make every effort to keep the medical information on our website updated, we cannot guarantee that the posted information reflects the most up-to-date research.
These articles do not imply an endorsement of BrightFocus by the author or their institution, nor do they imply an endorsement of the institution or author by BrightFocus.
Some of the content may be adapted from other sources, which will be clearly identified within the article.